help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanyicska, B.
Right arrow Articles by Freeman, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanyicska, B.
Right arrow Articles by Freeman, M. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DOPAMINE

Endocrinology, Vol 136, 990-994, Copyright © 1995 by Endocrine Society


ARTICLES

Long term exposure to dopamine reverses the inhibitory effect of endothelin-1 on prolactin secretion

B Kanyicska, JD Livingstone and ME Freeman
Department of Biological Science, Florida State University, Tallahassee 32306.

This study was undertaken to assess the possibility that endothelin-1 (ET-1) and dopamine (DA) can act in concert to modulate PRL secretion. Enzymatically dispersed anterior pituitary cells obtained from random cycling female rats were perifused with Dulbecco's Modified Eagle's Medium supplemented with 0.2% BSA and 100 microM ascorbic acid. In the absence of dopamine, ET-1 (applied at 20 nM for 60 min) rapidly evoked a small transient elevation of PRL release, followed by a sustained inhibitory phase. Overnight perfusion with 500 nM DA-supplemented medium did not change the basic character of ET-1's effects on PRL secretion. Continuation of DA exposure for 48 h dramatically shifted the responsiveness of the lactotrophs to ET-1; the fast stimulatory response was robustly enhanced, whereas the inhibitory phase was replaced by a modest secondary elevation of basal PRL secretion. The stimulatory effect of ET-1 on PRL secretion after DA pretreatment was blocked by an ETA receptor antagonist, BQ-123. The effect of DA can be mimicked completely by a specific D2 receptor agonist (+/-)-2-(N-phenyl- N-propyl)amino-5-hydroxytetraline hydrochloride, whereas pretreatment with a D1 agonist, SKF-39393, failed to change the responsiveness of lactotrophs to ET-1. Our data indicate that persistent activation of D2 receptors, a condition most closely resembling the in vivo environment of the lactotrophs, uncouples the inhibitory signaling pathway from the ETA receptor while synergistically affecting signal transduction, which mediates the ET-induced stimulation of PRL secretion.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
N. Hatae, N. Aksentijevich, H. W. Zemkova, K. Kretschmannova, M. Tomic, and S. S. Stojilkovic
Cloning and Functional Identification of Novel Endothelin Receptor Type A Isoforms in Pituitary
Mol. Endocrinol., May 1, 2007; 21(5): 1192 - 1204.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
R. Bertram, J. Tabak, N. Toporikova, and M. E. Freeman
Endothelin Action on Pituitary Lactotrophs: One Receptor, Many GTP-Binding Proteins
Sci. Signal., January 24, 2006; 2006(319): pe4 - pe4.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-L. He, A. E. Gonzalez-Iglesias, and S. S. Stojilkovic
Role of Nucleotide P2 Receptors in Calcium Signaling and Prolactin Release in Pituitary Lactotrophs
J. Biol. Chem., November 21, 2003; 278(47): 46270 - 46277.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Tomic', F. Van Goor, M.-L. He, D. Zivadinovic, and S. S. Stojilkovic
Ca2+-Mobilizing Endothelin-A Receptors Inhibit Voltage-Gated Ca2+ Influx through Gi/o Signaling Pathway in Pituitary Lactotrophs
Mol. Pharmacol., June 1, 2002; 61(6): 1329 - 1339.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy
Prolactin: Structure, Function, and Regulation of Secretion
Physiol Rev, October 1, 2000; 80(4): 1523 - 1631.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. Zivadinovic, F. Van Goor, D. Yuan, T.-a. Koshimizu, and S. S. Stojilkovic
Expression of Ca2+-Mobilizing EndothelinA Receptors and Their Role in the Control of Ca2+ Influx and Growth Hormone Secretion in Pituitary Somatotrophs
J. Neurosci., September 15, 1999; 19(18): 7721 - 7731.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Levenson, J. H. Byrne, and A. Eskin
Levels of Serotonin in the Hemolymph of Aplysia Are Modulated by Light/Dark Cycles and Sensitization Training
J. Neurosci., September 15, 1999; 19(18): 8094 - 8103.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. Kanyicska, A. Lerant, and M. E. Freeman
Endothelin Is an Autocrine Regulator of Prolactin Secretion
Endocrinology, December 1, 1998; 139(12): 5164 - 5173.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Lachowicz, F. Van Goor, A. C. Katzur, G. Bonhomme, and S. S. Stojilkovic
Uncoupling of Calcium Mobilization and Entry Pathways in Endothelin-stimulated Pituitary Lactotrophs
J. Biol. Chem., November 7, 1997; 272(45): 28308 - 28314.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. Kanyicska, M. E. Freeman, and S. E. Dryer
Endothelin Activates Large-Conductance K+ Channels in Rat Lactotrophs: Reversal by Long-Term Exposure to Dopamine Agonist
Endocrinology, August 1, 1997; 138(8): 3141 - 3153.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society